Although there is abundant data establishing the human immunodeficiency virus (HIV) as the etiologic agent of AIDS, the factors that determine which individuals will develop AIDS, less severe symptomatic infection or mild HIV disease for months or years progress to AIDS is also unknown. Human cytomegalovirus (HCMV) is a major pathogen in AIDS, is known to infect the same cells as HIV, and is frequently proposed as an important cofactor for the development and/or progression of AIDS. In our preliminary experiments, we have found that HCMV infection can markedly affect the HIV infection in tissue culture. We have also found that HIV infection is enhanced in cell infected with an amphotropic retrovirus and have evidence that HIV pseudotypes with amphotropic envelope proteins may be formed. We hypothesize that coinfection of peripheral blood mononuclear cells by HIV and either HCMV or other viruses can affect HIV entry into cells and affect the gene expression of both viruses at either a transcriptional or posttranscriptional level, thereby contributing to the development and progression of AIDs. We further hypothesize that infection of the same cell by HIV and a second enveloped virus may lead to alterations in the HIV envelope-forming pseudotypes, thus expanding the tissue tropism and pathogenicity of HIV. The objectives of the proposed studies are to elucidate the molecular interactions of HIV and HCMV, specifically in monocyte/macrophages, glial cells, and peripheral blood mononuclear cells. In particular, we will examine the effect of dual infection by HIV and HCMV with respect to viral gene expression, virus production, and potential HIV pseudotype formation with HCMV envelope proteins. The molecular basis of the interaction between in cis-acting regulatory regions of the HIV genome and trans-acting factors induced by the HCMV infection or specified by HCMV immediate early genes will be further examined by transient expression assays in these cells. In addition, we propose to create a packaging CEM cell line expression amphotropic retrovirus proteins, which will be used to produce HIV pseudotypes with expanded cellular tropism. The HIV progeny from this packaging cell line can be used for efficient infection of CD4- cell and examination of the HIV/HCMV interaction in such cells. Finally, we will assay the blood from AIDS patients during periods of HCMV viremia for the presence of HIV pseudotypes. The long- range goal of this research is to gain an understanding of the role of viral cofactors in AIDs, thus providing the basis for development of strategies for prevention and treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI028270-01
Application #
3142645
Study Section
(ARR)
Project Start
1989-04-01
Project End
1994-01-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Spector, S A (1999) Oral ganciclovir. Adv Exp Med Biol 458:121-7
Marschner, I C; Collier, A C; Coombs, R W et al. (1998) Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis 177:40-7
Smith, I L; Taskintuna, I; Rahhal, F M et al. (1998) Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol 116:178-85
Moreno, T N; Fortunato, E A; Hsia, K et al. (1997) A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells. J Virol 71:3693-701
Hsia, K; Spector, D H; Spector, S A (1997) Molecular analysis of the differential restriction of human immunodeficiency virus type 1 replication in neuronal cell lines. J Gen Virol 78 ( Pt 12):3255-64
Spector, S A (1997) Detection and quantification of human cytomegalovirus (CMV) as a marker for development of CMV disease and survival in patients with AIDS. Antivir Ther 2:200-5
Noraz, N; Lathey, J L; Spector, S A (1997) Human cytomegalovirus-associated immunosuppression is mediated through interferon-alpha. Blood 89:2443-52
Shinkai, M; Bozzette, S A; Powderly, W et al. (1997) Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Infect Dis 175:302-8
Spector, S A; Hsia, K; Wolf, D et al. (1995) Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens. Clin Infect Dis 21 Suppl 2:S170-3
Koval, V; Jault, F M; Pal, P G et al. (1995) Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences. J Virol 69:1645-51

Showing the most recent 10 out of 15 publications